These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 9125552

  • 1. Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.
    Singh M, Li XM, Wang H, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT.
    Infect Immun; 1997 May; 65(5):1716-21. PubMed ID: 9125552
    [Abstract] [Full Text] [Related]

  • 2. Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models.
    Singh M, Li XM, Wang H, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT.
    Vaccine; 1998 Feb; 16(4):346-52. PubMed ID: 9607054
    [Abstract] [Full Text] [Related]

  • 3. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS, Katare YK, Lalwani K, Ali MM, Singh O, Panda AK.
    Int J Pharm; 2002 Oct 01; 245(1-2):109-21. PubMed ID: 12270248
    [Abstract] [Full Text] [Related]

  • 4. Immunogenicity and lower dose requirement of polymer entrapped tetanus toxoid co-administered with alum.
    Katare YK, Panda AK.
    Vaccine; 2006 Apr 24; 24(17):3599-608. PubMed ID: 16513224
    [Abstract] [Full Text] [Related]

  • 5. Enhanced immune response with a combination of alum and biodegradable nanoparticles containing tetanus toxoid.
    Raghuvanshi RJ, Mistra A, Talwar GP, Levy RJ, Labhasetwar V.
    J Microencapsul; 2001 Apr 24; 18(6):723-32. PubMed ID: 11695637
    [Abstract] [Full Text] [Related]

  • 6. Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.
    Kanchan V, Katare YK, Panda AK.
    Eur J Pharm Sci; 2009 Aug 12; 38(1):18-28. PubMed ID: 19467323
    [Abstract] [Full Text] [Related]

  • 7. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
    Jung T, Koneberg R, Hungerer KD, Kissel T.
    Int J Pharm; 2002 Mar 02; 234(1-2):75-90. PubMed ID: 11839439
    [Abstract] [Full Text] [Related]

  • 8. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK, Griffin P, Rivera R, Siber GR.
    Dev Biol Stand; 1998 Mar 02; 92():277-87. PubMed ID: 9554282
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of immune response from polymer-entrapped antigen: toward development of single dose tetanus toxoid vaccine.
    Katare YK, Panda AK, Lalwani K, Haque IU, Ali MM.
    Drug Deliv; 2003 Mar 02; 10(4):231-8. PubMed ID: 14612338
    [Abstract] [Full Text] [Related]

  • 10. A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens.
    Singh M, Ugozzoli M, Kazzaz J, Chesko J, Soenawan E, Mannucci D, Titta F, Contorni M, Volpini G, Del Guidice G, O'Hagan DT.
    Vaccine; 2006 Mar 06; 24(10):1680-6. PubMed ID: 16300864
    [Abstract] [Full Text] [Related]

  • 11. Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology.
    Baxendale A, van Hooff P, Durrant LG, Spendlove I, Howdle SM, Woods HM, Whitaker MJ, Davies OR, Naylor A, Lewis AL, Illum L.
    Int J Pharm; 2011 Jul 15; 413(1-2):147-54. PubMed ID: 21554938
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of a diphtheria and tetanus PLGA microencapsulated vaccine formulation without stabilizers.
    Quintilio W, Takata CS, Sant'Anna OA, da Costa MH, Raw I.
    Curr Drug Deliv; 2009 Jul 15; 6(3):297-04. PubMed ID: 19604144
    [Abstract] [Full Text] [Related]

  • 13. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
    Jung T, Kamm W, Breitenbach A, Hungerer KD, Hundt E, Kissel T.
    Pharm Res; 2001 Mar 15; 18(3):352-60. PubMed ID: 11442276
    [Abstract] [Full Text] [Related]

  • 14. Immunogenicity of IRIV- versus alum-adjuvanted diphtheria and tetanus toxoid vaccines in influenza primed mice.
    Zurbriggen R, Glück R.
    Vaccine; 1999 Mar 17; 17(11-12):1301-5. PubMed ID: 10195764
    [Abstract] [Full Text] [Related]

  • 15. Parameters affecting the immunogenicity of microencapsulated tetanus toxoid.
    Esparza I, Kissel T.
    Vaccine; 1992 Mar 17; 10(10):714-20. PubMed ID: 1523881
    [Abstract] [Full Text] [Related]

  • 16. Influence of particle size, antigen load, dose and additional adjuvant on the immune response from antigen loaded PLA microparticles.
    Katare YK, Muthukumaran T, Panda AK.
    Int J Pharm; 2005 Sep 14; 301(1-2):149-60. PubMed ID: 16023313
    [Abstract] [Full Text] [Related]

  • 17. Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid.
    Higaki M, Azechi Y, Takase T, Igarashi R, Nagahara S, Sano A, Fujioka K, Nakagawa N, Aizawa C, Mizushima Y.
    Vaccine; 2001 Apr 30; 19(23-24):3091-6. PubMed ID: 11312003
    [Abstract] [Full Text] [Related]

  • 18. Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice.
    Singh M, Li XM, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT.
    Vaccine; 1997 Apr 30; 15(5):475-81. PubMed ID: 9160514
    [Abstract] [Full Text] [Related]

  • 19. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS, Rao YU, Singh P, Prabakaran D, Gupta S, Jain A, Vyas SP.
    Int J Pharm; 2005 Apr 27; 294(1-2):23-32. PubMed ID: 15814228
    [Abstract] [Full Text] [Related]

  • 20. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
    Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR.
    Vaccine; 1997 Nov 27; 15(16):1716-23. PubMed ID: 9364673
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.